Delivery Order SPE2DB20D1109-SPE2DB25FN00X

Award Date 10/30/24
Potential Completion Date 10/31/24
Potential Value $9.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp (DUNS: KABZK8W6PQT3) is a Firm Fixed Price Delivery Order worth $9,105.05, awarded by the Defense Logistics Agency (DLA). The contract is for the provision of MOVANTIK 12.5 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of February 27, 2025. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,632.62 firm fixed price delivery order is for the supply of 4567445213 - MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,673.45, is a Firm Fixed Price Delivery Order for the supply of Movantik 25 mg tablets. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order valued at $2,017.58 for the supply of MOVANTIK 25 MG TABLET 30S. The contract has a completion date of February 24, 2025 and is a Firm Fixed Price arrangement. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,551.92, is for the delivery of MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 5, 2024. The contract is not set aside for any specific socioeconomic group....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of MOVANTIK 25 MG TABLET 30S. The contract, valued at $1,951.24, is a delivery order that runs through May 3, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a for-profit organization registered in the System for Award Management (SAM.gov). The contract does not have a set-aside...
This is a $6,470.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The order has an ultimate completion date of August 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
This federal contract award, valued at $19,075.88, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the medical product MOVANTIK 25 MG TABLET UD 100S, with a firm fixed price and an ultimate completion date of December 19, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,116.80, is for the supply of 4567490665 MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The contract does not have a set-aside designation, indicating it was awarded through open competition. The contract is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,232.86 firm fixed-price delivery order contract has an ultimate completion date of March 4, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB25FN00X
    Delivery Order

This federal contract award SPE2DB20D1109|SPE2DB25FN00X, valued at $9,076.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the medication MOVANTIK 25 MG TABLET 30S and has a completion date of October 31, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 11:16 AM